knowledge -WSS

knowledge

author：entertainment 2025-09-28 15:20:52 - browse：962

intarcia implant. -- health tech coverage from STAT — The matchstick-sized, implantable device from Intarcia Therapeutics releases a steady, continuous, and low-dose stream of a drug for diabetes. Stuart Isett/Fortune Brainstorm Health

An advisory panel to the Food and Drug Administration unanimously voted against a diabetes implant from Intarcia Therapeutics — a former biotech unicorn that faltered after the FDA rejected said implant not once, but twice.

Intarcia called for the panel meeting because of those two rejections, seeking outside input on the FDA’s decision. FDA then granted Intarcia’s request. The agency is not bound to advisory panel decisions, though it tends to follow their advice.

Intarcia started developing its lead therapy, a small, skinny bar implanted under the skin, for type 2 diabetes patients in 2016. The implant delivers a glucose-controlling medicine called exenatide, a member of the GLP-1 drugs that have taken the diabetes and obesity markets by storm. Intarcia’s implant continuously administers the drug over six months, with the goal of improving patient adherence compared to Eli Lilly and Novo Nordisk’s weekly GLP-1 shots.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Flagship Pioneering startup Sonata Therapeutics lays off 21

Wikipedia

WSS

Neuroscience renaissance leads to new crop of psychiatric drugs

Elisabeth Bik tackles the widespread issue of research misconduct

Cholera vaccine supplies dangerously low, outbreaks surging

New study raises questions about niacin and heart health

Study fuels hope CAR

Abridge raises $150m as clinical notes automation market heats up

hotspot

knowledge

focus

23andMe had bad news about my health. I wish a person had delivered it

Flagship Pioneering startup Sonata Therapeutics lays off 21

Apple is now the first public company to be valued at $3 trillion

Elevance, SCAN deals highlight health insurer acquisition scrutiny

The high cost of giving birth even with insurance

'Vaccine

Dobbs anniversary: the lost opportunity of abortion as health care

Medicare isn't yet testing food as medicine

Virginia high school admissions case could be legal follow

CDC panel: People 65 and older should get a Covid spring booster shot

entertainment

Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

Researchers tackle phage therapy hurdles for wider adoption

Virtual repurposing can help discover new uses for existing drugs

STAT Madness 2024: Meet the contenders

Children’s Hospital revives plan for pedestrian bridge

STAT Madness 2024: Meet the contenders

hotspot

knowledge

Wikipedia

focus